Morera J, Guillaume A, Courtheoux P, Palazzo L, Rod A, Joubert M, Reznik Y
Endocrinology Unit, Centre Hospitalo-Universitaire de Caen, Avenue de la côte de Nacre, CS 30001, 14033, Caen Cedex 9, France.
Diagnostic Radiology Unit, Centre Hospitalo-Universitaire de Caen, Avenue de la côte de nacre, CS 30001, 14033, Caen Cedex 9, France.
J Endocrinol Invest. 2016 Apr;39(4):455-63. doi: 10.1007/s40618-015-0406-4. Epub 2015 Nov 17.
Preoperative localization of an insulinoma is recommended to improve the cure rate, but non-invasive procedures can fail to detect the tumour. The objective of the study was to assess the performance of a selective arterial calcium stimulation test in the preoperative localization of insulinomas that were not detected by conventional imaging procedures.
We conducted a monocenter retrospective case review of 13 patients who had endogenous hyperinsulinism and were treated between 1994 and 2013. Patients were selected on the basis of negative or doubtful non-invasive preoperative imaging. A selective arterial calcium stimulation test was performed by pancreatic and hepatic arteriography with selective intra-arterial calcium stimulation and hepatic venous sampling in order to obtain the plasma insulin measurement. We evaluated the efficacy of the test by comparing the results with an endoscopic ultrasound.
Twelve of the 13 patients underwent surgery, and the presence of an insulinoma was proven in 11 patients by pathological analysis of the tumour. An endoscopic ultrasound was consistent with surgery in 71.4 % of cases, while selective arterial calcium stimulation was consistent with surgery in 90.9 % and allowed detection of an insulinoma in two additional patients with a negative endoscopic ultrasound. One false-negative and one false-positive arterial calcium test were observed. No adverse events were recorded except transient skin flush following calcium injection in one patient.
The selective arterial calcium stimulation test is a sensitive diagnostic procedure for localizing insulinomas and may be considered when non-invasive radiological imaging does not allow the detection of an occult insulinoma.
推荐对胰岛素瘤进行术前定位以提高治愈率,但非侵入性检查可能无法检测到肿瘤。本研究的目的是评估选择性动脉钙刺激试验在术前定位常规成像检查未发现的胰岛素瘤中的性能。
我们对1994年至2013年间接受治疗的13例内源性高胰岛素血症患者进行了单中心回顾性病例分析。根据术前非侵入性成像阴性或可疑选择患者。通过胰腺和肝动脉造影进行选择性动脉钙刺激试验,选择性动脉内钙刺激并采集肝静脉血样以测量血浆胰岛素。我们通过将结果与内镜超声检查结果进行比较来评估该试验的有效性。
13例患者中有12例接受了手术,11例患者经肿瘤病理分析证实存在胰岛素瘤。内镜超声检查在71.4%的病例中与手术结果一致,而选择性动脉钙刺激试验在90.9%的病例中与手术结果一致,并且在另外两名内镜超声检查阴性的患者中检测到了胰岛素瘤。观察到1例假阴性和1例假阳性动脉钙试验结果。除1例患者注射钙后出现短暂皮肤潮红外,未记录到不良事件。
选择性动脉钙刺激试验是定位胰岛素瘤的一种敏感诊断方法,当非侵入性放射学成像无法检测到隐匿性胰岛素瘤时可考虑使用。